Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Healthy: early-phase trial registry
225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2 of 28,963 conditions by registered trial count.
1,096 US clinical trials · 225 currently recruiting · #2 of 28,963 conditions by registered trial count
Healthy: 1,096 US clinical trials tracked, 225 recruiting.
Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.
Open enrollment, early-phase tilt
Healthy has 1,096 registered US clinical trials, 225 of them open to new participants right now, about 21% of the total.
- 225
- recruiting participants now
- 21%
- of trials open to enrollment
- 43
- in Phase 3-4 (later-stage)
- 55
- top sponsor: Eli Lilly and Company
Corpus placement: #2 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Healthy is recruiting below its size-band peers.
225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Healthy trials is spread across many organizations.
Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.
-
Most Healthy trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.
-
Healthy research is mostly interventional.
905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
1,096 total, page 16 of 22
Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C
MassBiologics
NCT00952263
Neuromodulation of Cognition in Older Adults
University of Florida
NCT02137122
Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
Celgene
NCT01712828
Food Containing Resistant Starch Type 4 and Postprandial Glycemic Response
Clinical Nutrition Research Center, Illinois Institute of Technology
NCT03844503
A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)
Stealth BioTherapeutics
NCT01754818
Neuroimaging of Anesthetic Modulation of Human Consciousness
University of Michigan
NCT03361605
Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of Ricin
University of Texas Southwestern Medical Center
NCT00812071
A Phase 1 Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics of Tivozanib in Healthy Subjects
AVEO Pharmaceuticals
NCT01363778
Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers
SIGA Technologies
NCT00431951
Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers
Cardeas Pharma
NCT02709265
Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants
Janssen Scientific Affairs
NCT02984852
Use of Transcranial Magnetic Stimulation (TMS) and Magnetic Resonance Imaging (MRI) to Study Visual Attention
National Institute of Mental Health (NIMH)
NCT00006285
Energy Expenditure
Arkansas Children's Hospital Research Institute
NCT01068899
Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
Novo Nordisk A/S
NCT01401244
Staccato® Granisetron Multiple Dose PK
Alexza Pharmaceuticals
NCT04327765
Electromyography to Diagnose Neuromuscular Disorders
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00004553
Metronidazole Drug Interaction Study With MMX® Mesalazine/Mesalamine
Shire
NCT01418365
Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants
Duke University
NCT01431300
A Comparison Study of Three Standard Elbow Wrist Hand Orthoses to Limit Forearm Rotation
Mayo Clinic
NCT04130425
A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions
Actavis
NCT00864058
Cilostazol 50 mg Tablets Under Fasting Conditions
Teva Pharmaceuticals U
NCT00839930
Chiropractic Force Versus Touch
Life University
NCT05249530
A Study to Evaluate Endoflip Normal Ranges Data in Healthy Volunteers
Mayo Clinic
NCT04809883
Emotion Regulation and Cancer Caregiving
Stanford University
NCT06123416
A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions
Actavis
NCT00864019
A Study of LY3090106 in Japanese and Caucasian Healthy Participants
Eli Lilly and Company
NCT03736772
Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide)
National Institutes of Health Clinical Center (CC)
NCT00001845
A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
Eli Lilly and Company
NCT06370728
A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions
Actavis
NCT00865462
Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
Actavis
NCT00864604
Comparing the Effects of Upper and Lower Body Resistance Training on Pain Sensitivity
University of Central Florida
NCT05985382
Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine
Patricia L. Hibberd
NCT01545349
A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants
Pfizer
NCT05431153
A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems
Boehringer Ingelheim
NCT06692322
Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00025
Masimo Corporation
NCT04079816
Evaluating the Availability of Berry Phytonutrients Post-consumption of Fresh and Processed Blueberry by Healthy Adults
North Carolina State University
NCT04175106
A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function
Janssen Research & Development
NCT01309438
Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles
Environmental Protection Agency (EPA)
NCT01442480
Bioavailability Study Comparing Tolvaptan Administered Via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact
University of North Carolina, Chapel Hill
NCT01261481
An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
Pfizer's Upjohn has merged with Mylan to form Viatris
NCT01257529
A Study of the Effect of Itraconazole and Phenytoin on Calderasib (MK-1084) in Healthy Adults (MK-1084-008)
Merck Sharp & Dohme
NCT06719557
Circulatory Levels of Irisin in Response to Acute Resistance Training
Texas Tech University
NCT02478658
Assessing Student Learning of Spinal Mobilization With Real-time Objective Feedback
Youngstown State University
NCT05445622
Does Mindfulness Training Change the Processing of Social Threat?
Massachusetts General Hospital
NCT00992875
A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Eli Lilly and Company
NCT05906836
A Study to Assess ACH-0145228 When Administered as Immediate Release Tablet Versus Powder-In-Capsule in Healthy Adult Participants
Alexion Pharmaceuticals
NCT04551586
To Assess the Bioequivalence of Two Pacritinib Drug Product Formulations and FMI Formulation Following Oral Administration in Healthy Subjects
CTI BioPharma
NCT02823171
Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects
Regeneron Pharmaceuticals
NCT02741739
A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Participants
Eli Lilly and Company
NCT06258174
Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin
Kowa Research Institute
NCT01422382
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 518 |
| Phase 2 | 28 |
| Phase 3 | 11 |
| Phase 4 | 32 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Healthy right now
225 recruiting of 1,096 indexed (21% open).
Phase mix: 43 late (III/IV) vs 546 early (I/II) (early-phase heavy).
Top sponsor: Eli Lilly and Company (55 trials), 9 others listed. 50 shown below, recruiting first. #2 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Healthy?
PlainTrial tracks 1,096 US clinical trials for Healthy, of which 225 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Healthy?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.